ReviewInternational journal of molecular sciences2026
Recent Advances in Synthetic Strategies and Medicinal Properties of Thienopyridines.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This review provides an updated overview of recent advances (2024-present) in the synthesis and medicinal applications of thienopyridines and their fused derivatives. Synthetic methodologies are categorized into three strategic approaches: (i) thiophene ring construction onto a preformed pyridine core; (ii) pyridine ring annulation onto a thiophene scaffold-ranging from classical Friedländer and Gould-Jacobs reactions to modern metal-catalyzed, photo-induced, and electrochemical transformations; and (iii) multicomponent reactions for the simultaneous assembly of both heterocyclic rings. Furthermore, the strategic functionalization of preformed thienopyridine scaffolds to access complex tri- and polyheterocyclic systems is discussed. From a biological perspective, the review highlights the scaffold's expanding therapeutic repertoire, including antibacterial, antifungal, and antiviral activities; potent anticancer applications targeting tumor-associated enzymes and emerging Proteolysis Targeting Chimera (PROTAC)/Deubiquitinase-Targeting Chimera (DUBTAC) technologies; and modulation of neurological, neuropsychiatric, and metabolic disorders. Finally, recent progress in the agrochemical utility of thienopyridines as insecticides and herbicide safeners is examined. Collectively, this work underscores the enduring relevance of the thienopyridine scaffold as a versatile platform for next-generation drug and agrochemical discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.